腦脊髓液 (CSF) 管理 - 全球市場回顧、競爭格局、市場預測 (2030)

預計 2024 年至 2030 年預測期內，全球腦脊髓液 (CSF) 管理市場規模將以 4.78% 的複合年增長率成長。 由於事故和創傷數量增加、腦腫瘤盛行率增加、兒童腦積水盛行率增加、對先進技術產品的需求增加以及老年人口的增加，對腦脊髓液（CSF）管理的需求增加，預計將推動產品需求在全球腦脊髓液（CSF）管理市場。

腦脊髓液 (CSF) 管理的市場動態

由於腦腫瘤盛行率上升，腦脊髓液 (CSF) 管理市場的市場收入增加。 腦腫瘤與腦脊髓液在大腦中的積聚有關，最終導致大腦內顱內壓升高。 根據國際癌症研究機構 2020 年發布的 GLOBOCAN 研究，2020 年全球腦腫瘤病例為 308,102 例。 過多的液體會給大腦帶來壓力並導致腦損傷。 因此，採用腦脊髓液分流器和引流系統等腦脊髓液管理裝置來避免腦部積液。 因此，全球腦腫瘤的增加預計將增加對腦脊髓液管理設備的需求，從而導致全球腦脊髓液管理市場的成長。

道路事故造成的傷害增加也被認為是腦脊髓液管理設備市場的主要成長因素之一。 根據世界衛生組織 (WHO) 道路交通傷害情況說明書 (2023)，道路交通傷害是全球 5 至 29 歲兒童和年輕人死亡的主要原因。 情況說明書進一步指出，大約 2,000 萬至近 5,000 萬人因道路交通事故遭受非致命傷害，並因此留下殘疾。 這種性質的傷害可能導致嚴重的頭部外傷。 結果，大腦中可能形成血塊並限制腦脊髓液在大腦內的流動。 結果，腦脊髓液在大腦中積聚，並在腦脊髓液管理設備的幫助下進行治療。 因此，道路事故和傷害的增加預計將導致對腦脊髓液（CSF）管理設備的需求增加，進而推動預測期內的全球腦脊髓液（CSF）管理市場。

然而，嚴格的產品審批流程以及與設備相關的常見風險（例如感染、分流功能障礙和引流不當）仍然是腦脊髓液（CSF）管理市場成長的某些限制因素。

除上述因素外，由於為遏制 COVID-19 傳播而實施的全國範圍內的封鎖等必要措施，全球腦脊髓液 (CSF) 管理市場遭受了暫時的挫折。曾經有一段時間。 這段時間的主要措施之一是暫停許多擇期手術和門診。 這導致各科室大量手術以非必要為由暫停，部分重症監護室因封城初期患者人數減少而關閉，導致腦脊髓液供應量下降市場上管理設備的需求減少，從而在短時間內限制了市場的增長。 然而，由於世界各地多種 COVID-19 疫苗的批准和管理，腦脊髓液 (CSF) 管理設備市場正在經歷一段復甦期，包括醫療保健服務在內的各個領域都已恢復活動。

腦脊髓液（CSF）管理細分市場分析

在 CSF 管理市場的產品領域，CSF 分流器和閥門預計將在預測期內佔據市場的主要收入份額。 它最常用於因腦室內出血或脊柱裂導致的腦積水/液體滯留的兒科患者，其在腦積水治療中的應用極大地改善了與這些疾病相關的臨床結果。這可能是由於可能性。 此外，與其他腦脊髓液管理設備相比，它旨在終身使用，從而提供更持久的治療方法。

此外，產品開發方面的技術進步，例如開發具有避免腦脊髓液過度引流的電子（外部）可編程組件的新型特技，也可能對腦脊髓液管理市場對該產品類型的需求產生積極影響。成為一個促成因素。

本報告提供了全球腦脊髓液 (CSF) 管理市場的研究和分析，包括市場規模和預測、驅動因素和挑戰以及公司和產品概況。

目錄

第1章腦脊髓液 (CSF) 管理市場報告簡介

第 2 章腦脊髓液 (CSF) 管理市場執行摘要

• 調查範圍
• 市場概覽
• 競爭評估
• 財務基準

第3章監理與專利分析

• 美國
• 歐洲
• 日本
• 中國

第4章腦脊髓液（CSF）管理市場關鍵因素分析

• 腦脊髓液 (CSF) 管理市場驅動因素
  • 腦積水盛行率增加
  • 受傷和事故數量不斷增加
  • 腦腫瘤盛行率不斷上升
  • 更重視創新產品開發
• 腦脊髓液 (CSF) 管理市場的限制和挑戰
  • 與設備相關的風險
  • 嚴格的產品審批流程
• 腦脊髓液 (CSF) 管理市場機遇
  • 開發具有抗菌性能的設備
  • 提高產品安全性

第5章腦脊髓液 (CSF) 管理市場的波特五力分析

第6章 COVID-19 對腦脊髓液 (CSF) 管理市場的影響分析

第7章腦脊髓液（CSF）管理市場佈局

• 依產品類型
  • 腦脊髓液分流器、閥門
  • 體外引流系統
  • 防虹吸裝置
  • 其他
• 依年齡段
  • 成人
  • 兒童
• 按最終用戶
  • 醫院
  • 專科診所
• 按地區
  • 北美
  • 歐洲
  • 亞太地區
  • 其他領域

第 8 章腦脊髓液 (CSF) 管理市場：全球公司份額分析 - 3 至 5 家主要公司

第 9 章腦脊髓液 (CSF) 管理市場公司與產品概況

• Medtronic
• B. Braun Melsungen AG
• Neuromedex GmbH
• Natus Medical Incorporated
• Sophysa
• Integra LifeSciences Corporation
• Spiegelberg GmbH & Co. KG
• Desu Medical
• Polyganics
• CHRISTOPH MIETHKE GMBH & CO. KG
• HpBio Proteses Inc
• Wellong Instruments Co., Ltd.
• Moller Medical GmbH
• RAUMEDIC AG
• Anuncia Inc
• Vivonics Inc
• CereVasc Inc

第10章KOL觀看次數

第 11 章專案方法

第 12 章關於 DelveInsight

第 13 章免責聲明與聯絡資訊

Cerebrospinal Fluid Management Market By Product Type (Csf Shunts & Valves, External Drainage Systems [Drainage And Monitoring Systems, Drainage-Specific Systems, And Csf Drainage Catheters {Ventricular, Lumbar, And Others}], Anti-Siphon Devices, And Others), By Age Group (Adult And Pediatric), By End User (Hospitals And Specialty Clinics), by geography is expected to grow at a steady CAGR forecast till 2030 owing to the rising prevalence of hydrocephalus due to brain tumors and road accidents.

Global Cerebrospinal Fluid Management Market will grow at a CAGR of 4.78% during the forecast period from 2024 to 2030. The demand for CSF management is witnessing growth due to the rising number of accident and trauma cases, growing prevalence of brain tumors, increasing cases of childhood hydrocephalus, rising demand for technologically advanced products, and increasing geriatric population are expected to drive the product demand in the global CSF management market.

Cerebrospinal Fluid Management Market Dynamics:

The cerebrospinal fluid (CSF) management market is witnessing an increase in market revenue owing to the rising prevalence of brain tumors. Brain tumors are associated with the accumulation of CSF in the brain which ultimately result in the increase of the intracranial pressure inside the brain. As per the GLOBOCAN study published by the International Agency for Research on Cancer published in 2020, brain cancers accounted for 308,102 cases across the globe in 2020. The excess fluid puts pressure on the brain, which can damage it. Therefore, in order to avoid the fluid buildup inside the brain, CSF management devices such as CSF shunts and drainage systems are employed. Therefore, the rising global prevalence of brain tumors is expected to result in the growing demand for CSF management devices, thereby aiding in the global CSF management market growth.

Increasing cases of road traffic injuries can be considered as another key factor responsible for the growth of the CSF management devices market. According to the World Health Organization factsheet (2023) on road traffic injuries, injuries associated with road accidents are the leading cause of fatality in children and young adults belonging to the age group 5-29 years across the globe. The same factsheet further stated that near about 20-50 million people suffer from non-fatal injuries in road accidents resulting in a disability as a result of their injury. Injuries of this nature may result in severe head trauma. This may result in formation of blood clots inside the brain which may restrict the flow of CSF inside the brain. This in turn leads to the accumulation of CSF inside the brain, which in turn would be treated with the help of CSF management devices. Therefore, the increase in the cases of road traffic injuries and accidents is expected to contribute in the growing demand for cerebrospinal fluid management devices, eventually taking the global cerebrospinal fluid management market forward during the forecast period.

However, stringent product approval process, common risks associated with the devices such as infection, shunt malfunction, and improper drainage, among others may prove to be certain restraints to the CSF management market growth.

Along with the above-mentioned factors, the global cerebrospinal fluid management market witnessed a period of temporary setback as necessary measures to contain the COVID-19 spread were imposed such as country-wide lockdowns. One of the major steps during this was the suspension of numerous elective procedures and outpatient visits which reduced the demand for CSF management devices in the market as a large number of surgeries across different medical specialties were suspended on account of either being non-essential or several of intensive care units were closed because of the reduction in number of patient during the initial lockdown period, thereby limiting the market growth for a short time. However, the market for CSF management devices is on the period of recovery with the resumption of activities across various domains including healthcare services owing to the approval and administration of numerous COVID-19 vaccines across the globe, thereby presenting a positive future outlook for the cerebrospinal fluid management market during the forecast period.

Cerebrospinal Fluid Management Market Segment Analysis:

Cerebrospinal Fluid Management Market by Product Type (CSF Shunts & Valves, External Drainage Systems [Drainage and Monitoring Systems, Drainage-specific Systems, and CSF Drainage Catheters {Ventricular, Lumbar, and Others}], Anti-Siphon Devices, and Others), by Age Group (Adult and Pediatric), by End User (Hospitals and Specialty Clinics), and by Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product segment of the CSF management market, the CSF shunts and valves are expected to account for a significant revenue share in the market during the forecast period. This can be attributed to their applicability in the treatment of hydrocephalus as they are most commonly placed in pediatric patients for hydrocephalus/fluid space collections due to intraventricular hemorrhage or spina bifida and have significantly improved clinical outcomes associated with these conditions. Furthermore, they offer a more permanent treatment approach compared to other CSF management devices as they are intended to remain in place for life.

Additionally, the technological advancement in product development such as the development of newer stunts with an electronically (externally) programmable component that would be help avoid over-drainage of CSF may be another key factor positively influencing the demand for this product type in the CSF management market.

North America is expected to dominate the Overall Cerebrospinal Fluid Management Market:

Among all the regions, North America is estimated to account for the significant market share in the CSF management market. North America is predicted to account for the dominant market share because of the high prevalence of hydrocephalus from various reasons such as congenital hydrocephalus, brain aneurysms, traumatic brain injury among other factors, rising population of the elderly as well as high awareness among people regarding disease management and the new product launches in the region.

The North America CSF management market is witnessing an upward trend due to the rising prevalence of congenital hydrocephalus in the country among other factors. As per the data provided by the Centers for Disease Control and Prevention, each year, about 1,427 babies are born with spina bifida, or 1 in every 2,758 births in the country. Many babies born with spina bifida also develop hydrocephalus which may boost the demand for CSF management devices such as hydrocephalus shunts, eventually driving the United States CSF management market growth during the forecast period.

Additionally, according to the data (2023) provided by the Brain Aneurysm Foundation, a US-based organization, an estimated 6.5 million people in the United States have an un-ruptured brain aneurysm. The annual rate of rupture in the country is approximately 8 - 10 per 100,000 people. About 30,000 people in the United States suffer a brain aneurysm rupture each year. A brain aneurysm ruptures every 18 minutes. It has been established that blood from a torn aneurysm can result in the blockage of CSF circulation leading to fluid buildup and increased pressure on the brain ultimately causing hydrocephalus. Therefore, the increase in number of patients suffering from brain aneurysms in the country is expected to drive the demand for CSF management devices, thereby contributing in the overall growth of the CSF management market in the North American region.

The above-mentioned facts point towards the presence of diverse patient pool in the country as well as the North American region that may benefit from the utilization of CSF management. Furthermore, the well-established patient care system along with awareness among patients and caregivers regarding different types of neurosurgeries and products used is further expected to aid in the North American CSF management market growth.

Moreover, the prompt and well-established healthcare services and infrastructure further contributes to the growth of the regional CSF management market. The presence of key players in the region and supportive reimbursement programs further provide immense growth opportunities for CSF management market. Moreover, the constant focus of market players in targeting the region in product launch is further expected to aid in the growth of the North American CSF management market. For instance, in December 2019, Raumedic AG launched a new device for home use, Raumed Home ICP for intracranial pressure (ICP) monitoring in hydrocephalus patients.

Cerebrospinal Fluid Management Market Key Players:

Some of the key market players operating in the CSF management market includes Medtronic, B. Braun Melsungen AG, Neuromedex GmbH, Natus Medical Incorporated., Sophysa, Integra LifeSciences Corporation, Spiegelberg GmbH & Co. KG, Desu Medical, Polyganics, CHRISTOPH MIETHKE GMBH & CO. KG, HpBio Proteses Inc, Wellong Instruments Co., Ltd., Moller Medical GmbH, CereVasc, Inc., Anuncia Inc, RAUMEDIC AG, Vivonics Inc and others.

Recent Developmental Activities in Cerebrospinal Fluid Management Market:

In March 2022, Anuncia Inc. received the ""Breakthrough Device Designation"" for ReFlow(TM) System Mini by the US FDA. The device is to be used in the treatment of CSF disorders requiring shunting such as hydrocephalus.

In May, 2020, Aesculap, Inc. announced the launch of M.blue(TM) Hydrocephalus Valve in the United States. The device is equipped with a unique gravitational technology integrated with a fixed differential pressure unit in one valve, thereby providing a simple, position-dependent solution.

In July 2019, Integra LifeSciences Holdings Corporation acquired Arkis Biosciences Inc. thereby also acquiring a portfolio of neurosurgical devices, including the CerebroFlo external ventricular drainage (EVD) catheter with Endexo technology.

Key Takeaways from the Cerebrospinal Fluid Management Market Report Study

Market size analysis for current CSF management market size (2023), and market forecast for 5 years (2024-2030)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the CSF management market.

Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years

Key companies dominating the global CSF management market.

Various opportunities available for the other competitor in the CSF management market space.

What are the top performing segments in 2023? How these segments will perform in 2030.

Which is the top-performing regions and countries in the current CSF management market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for CSF management market growth in the coming future?

Target Audience who can be benefited from this Cerebrospinal Fluid Management Market Report Study

Cerebrospinal Fluid Management products providers

Research organizations and consulting companies

Cerebrospinal Fluid Management-related organizations, associations, forums, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders dealing in CSF management

Various End-users who want to know more about the CSF management market and latest technological developments in the CSF management market.

Frequently Asked Questions for Cerebrospinal Fluid Management Market:

1. What is a CSF Management Device?

CSF management devices are used in the treatment of CSF accumulation and leakage in events of hydrocephalus and injuries due to various reasons such as birth defects, trauma, and other causes. These include devices such as CSF shunts, dural sealants, and intracranial pressure monitoring devices among others.

2. What is the market for Global Cerebrospinal Fluid Management?

Global Cerebrospinal Fluid Management Market will grow at a CAGR of 4.78% during the forecast period from 2024 to 2030.

3. What are the drivers for Global Cerebrospinal Fluid Management Market?

The demand for CSF management is witnessing growth due to the rising number of accident and trauma cases, growing prevalence of brain tumors, increasing cases of childhood hydrocephalus, rising demand for technologically advanced products, and increasing geriatric population are expected to drive the product demand in the global CSF management market.

4. Who are the key players operating in Global Cerebrospinal Fluid Management Market?

Some of the key market players operating in the CSF management market includes Medtronic, B. Braun Melsungen AG, Neuromedex GmbH, Natus Medical Incorporated., Sophysa, Integra LifeSciences Corporation, Spiegelberg GmbH & Co. KG, Desu Medical, Polyganics, CHRISTOPH MIETHKE GMBH & CO. KG, HpBio Proteses Inc, Wellong Instruments Co., Ltd., Moller Medical GmbH, CereVasc, Inc., Anuncia Inc, RAUMEDIC AG, Vivonics Inc and others.

5. Which region has the highest share in Cerebrospinal Fluid Management market?

North America is predicted to account for the dominant market share because of the high prevalence of hydrocephalus from various reasons such as congenital hydrocephalus, brain aneurysms, traumatic brain injury among other factors, rising population of the elderly as well as high awareness among people regarding disease management and the new product launches in the region.

Table of Contents

1.Cerebrospinal Fluid Management Market Report Introduction

2.Cerebrospinal Fluid Management Market Executive Summary

• 2.1 Scope of the Study
• 2.2 Market at Glance
• 2.3 Competitive Assessment
• 2.4 Financial Benchmarking

3. Regulatory and Patent Analysis

• 3.1 The United States
• 3.2 Europe
• 3.3 Japan
• 3.4 China

4. Cerebrospinal Fluid Management Market Key Factors Analysis

• 4.1 Cerebrospinal Fluid Management Market Drivers
  • 4.1.1 Rising Prevalence of Hydrocephalus
  • 4.1.2 Rising Number of Trauma and Accident Cases
  • 4.1.3 Rising Prevalence of Brain Tumors
  • 4.1.4 Increasing Focus on Innovative Product Development
• 4.2 Cerebrospinal Fluid Management Market Restraints and Challenges
  • 4.2.1 Risks Associated with Devices
  • 4.2.2 Stringent Product Approval Process
• 4.3 Cerebrospinal Fluid Management Market Opportunities
  • 4.3.1 Development of Devices with Antimicrobial Properties
  • 4.3.2 Product Improvement in Terms of Safety

5. Cerebrospinal Fluid Management Market Porter's Five Forces Analysis

• 5.1 Bargaining Power of Suppliers
• 5.2 Bargaining Power of Consumers
• 5.3 Threat of New Entrants
• 5.4 Threat of Substitutes
• 5.5 Competitive Rivalry

6. COVID-19 Impact Analysis on Cerebrospinal Fluid Management Market

7. Cerebrospinal Fluid Management Market Layout

• 7.1 By Product Type
  • 7.1.1 CSF Shunts and Valves
  • 7.1.2 External Drainage Systems
    • 7.1.2.1 Drainage and Monitoring Systems
    • 7.1.2.2 Drainage-Specific Systems
    • 7.1.2.3 CSF Drainage Catheters
    • 7.1.2.3.1 Ventricular
    • 7.1.2.3.2 Lumbar
    • 7.1.2.3.3 Others
  • 7.1.4 Anti-Siphon Devices
  • 7.1.5 Others
• 7.2 By Age Group
  • 7.2.1 Adult
  • 7.2.2 Pediatric
• 7.3 By End User
  • 7.3.1 Hospitals
  • 7.3.2 Specialty Clinics
• 7.4 By Geography
  • 7.4.1 North America
    • 7.4.1.1 North America Cerebrospinal Fluid Management Market, by Product Type
    • 7.4.1.2 North America Cerebrospinal Fluid Management Market, by Age Group
    • 7.4.1.2 North America Cerebrospinal Fluid Management Market, by End User
    • 7.4.1.4 North America Cerebrospinal Fluid Management Market, by Country
    • 7.4.1.4.1 United States
    • 7.4.1.4.2 Canada
    • 7.4.1.4.3 Mexico
  • 7.4.2 Europe
    • 7.4.2.1 Europe Cerebrospinal Fluid Management Market, by Product Type
    • 7.4.2.2 Europe Cerebrospinal Fluid Management Market, by Age Group
    • 7.4.2.2 Europe Cerebrospinal Fluid Management Market, by End User
    • 7.4.2.4 Europe Cerebrospinal Fluid Management Market, by Country
    • 7.4.2.4.1 France
    • 7.4.2.4.2 Germany
    • 7.4.2.4.3 United Kingdom
    • 7.4.2.4.4 Italy
    • 7.4.2.4.5 Spain
    • 7.4.2.2.6 Russia
    • 7.4.2.2.7 Rest of Europe
  • 7.4.3 Asia-Pacific
    • 7.4.3.1 Asia-Pacific Cerebrospinal Fluid Management Market, by Product Type
    • 7.4.3.2 Asia-Pacific Cerebrospinal Fluid Management Market, by Age Group
    • 7.4.3.2 Asia-Pacific Cerebrospinal Fluid Management Market, by End User
    • 7.4.3.4 Asia-Pacific Cerebrospinal Fluid Management Market, by Country
    • 7.4.3.4.1 China
    • 7.4.3.4.2 Japan
    • 7.4.3.4.3 India
    • 7.4.3.4.4 Australia
    • 7.4.3.4.5 South Korea
    • 7.4.3.4.6 Rest of Asia Pacific
  • 7.4.4 Rest of the World (RoW)
    • 7.4.4.1 RoW Cerebrospinal Fluid Management Market, by Product Type
    • 7.4.4.2 RoW Cerebrospinal Fluid Management Market, by Age Group
    • 7.4.4.2 RoW Cerebrospinal Fluid Management Market, by End User
    • 7.4.4.4 RoW Cerebrospinal Fluid Management Market, by Region
    • 7.4.4.4.1 Middle East
    • 7.4.4.4.2 Africa
    • 7.4.4.4.3 South America

8. Cerebrospinal Fluid Management Market Global Company Share Analysis - Key 3-5 Companies

9. Cerebrospinal Fluid Management Market Company and Product Profiles

• 9.1 Medtronic
  • 9.1.1. Company Overview
  • 9.1.2. Company Snapshot
  • 9.1.3. Financial Overview
  • 9.1.4 Product Listing
  • 9.1.5. Entropy
• 9.2 B. Braun Melsungen AG
  • 9.2.1. Company Overview
  • 9.2.2. Company Snapshot
  • 9.2.3. Financial Overview
  • 9.2.4 Product Listing
  • 9.2.5. Entropy
• 9.3 Neuromedex GmbH
  • 9.3.1. Company Overview
  • 9.3.2. Company Snapshot
  • 9.3.3. Financial Overview
  • 9.3.4 Product Listing
  • 9.3.5. Entropy
• 9.4 Natus Medical Incorporated
  • 9.4.1. Company Overview
  • 9.4.2. Company Snapshot
  • 9.4.3. Financial Overview
  • 9.4.4 Product Listing
  • 9.4.5. Entropy
• 9.5 Sophysa
  • 9.5.1. Company Overview
  • 9.5.2. Company Snapshot
  • 9.5.3. Financial Overview
  • 9.5.4 Product Listing
  • 9.5.5. Entropy
• 9.6 Integra LifeSciences Corporation
  • 9.6.1. Company Overview
  • 9.6.2. Company Snapshot
  • 9.6.3. Financial Overview
  • 9.6.4 Product Listing
  • 9.6.5. Entropy
• 9.7 Spiegelberg GmbH & Co. KG
  • 9.7.1. Company Overview
  • 9.7.2. Company Snapshot
  • 9.7.3. Financial Overview
  • 9.7.4 Product Listing
  • 9.7.5. Entropy
• 9.8 Desu Medical
  • 9.8.1. Company Overview
  • 9.8.2. Company Snapshot
  • 9.8.3. Financial Overview
  • 9.8.4 Product Listing
  • 9.8.5. Entropy
• 9.9 Polyganics
  • 9.9.1. Company Overview
  • 9.9.2. Company Snapshot
  • 9.9.3. Financial Overview
  • 9.9.4 Product Listing
  • 9.9.5. Entropy
• 9.10 CHRISTOPH MIETHKE GMBH & CO. KG
  • 9.10.1. Company Overview
  • 9.10.2. Company Snapshot
  • 9.10.3. Financial Overview
  • 9.10.4 Product Listing
  • 9.10.5. Entropy
• 9.11 HpBio Proteses Inc
  • 9.11.1. Company Overview
  • 9.11.2. Company Snapshot
  • 9.11.3. Financial Overview
  • 9.11.4 Product Listing
  • 9.11.5. Entropy
• 9.12 Wellong Instruments Co., Ltd.
  • 9.12.1. Company Overview
  • 9.12.2. Company Snapshot
  • 9.12.3. Financial Overview
  • 9.12.4 Product Listing
  • 9.12.5. Entropy
• 9.13 Moller Medical GmbH
  • 9.13.1. Company Overview
  • 9.13.2. Company Snapshot
  • 9.13.3. Financial Overview
  • 9.13.4 Product Listing
  • 9.13.5. Entropy
• 9.14 RAUMEDIC AG
  • 9.14.1. Company Overview
  • 9.14.2. Company Snapshot
  • 9.14.3. Financial Overview
  • 9.14.4 Product Listing
  • 9.14.5. Entropy
• 9.15 Anuncia Inc
  • 9.15.1. Company Overview
  • 9.15.2. Company Snapshot
  • 9.15.3. Financial Overview
  • 9.15.4 Product Listing
  • 9.15.5. Entropy
• 9.16 Vivonics Inc
  • 9.16.1. Company Overview
  • 9.16.2. Company Snapshot
  • 9.16.3. Financial Overview
  • 9.16.4 Product Listing
  • 9.16.5. Entropy
• 9.17 CereVasc Inc
  • 9.17.1. Company Overview
  • 9.17.2. Company Snapshot
  • 9.17.3. Financial Overview
  • 9.17.4 Product Listing
  • 9.17.5. Entropy

10. KOL Views

11. Project Approach

12. About DelveInsight

13. Disclaimer & Contact Us

List of Tables

• Table 1 Competitive Analysis
• Table 2 COVID-19 Impact Analysis on Cerebrospinal Fluid Management Market
• Table 3 Cerebrospinal Fluid Management Market in Global (2021-2030)
• Table 4 Cerebrospinal Fluid Management Market in Global by Product Type (2021-2030)
• Table 5 Cerebrospinal Fluid Management Market in Global by Age Group (2021-2030)
• Table 6 Cerebrospinal Fluid Management Market in Global by End User (2021-2030)
• Table 7 Cerebrospinal Fluid Management Market in Global by Geography (2021-2030)
• Table 8 Cerebrospinal Fluid Management Market in North America (2021-2030)
• Table 9 Cerebrospinal Fluid Management Market in North America by Product Type (2021-2030)
• Table 10 Cerebrospinal Fluid Management Market in North America by Age Group (2021-2030)
• Table 11 Cerebrospinal Fluid Management Market in North America by End User (2021-2030)
• Table 12 Cerebrospinal Fluid Management Market in North America by Country (2021-2030)
• Table 13 Cerebrospinal Fluid Management Market in the US (2021-2030)
• Table 14 Cerebrospinal Fluid Management Market in Canada (2021-2030)
• Table 15 Cerebrospinal Fluid Management Market in Mexico (2021-2030)
• Table 16 Cerebrospinal Fluid Management Market in Europe (2021-2030)
• Table 17 Cerebrospinal Fluid Management Market in Europe by Product Type (2021-2030)
• Table 18 Cerebrospinal Fluid Management Market in Europe by Age Group (2021-2030)
• Table 19 Cerebrospinal Fluid Management Market in Europe by End User (2021-2030)
• Table 20 Cerebrospinal Fluid Management Market in Europe by Country (2021-2030)
• Table 21 Cerebrospinal Fluid Management Market in France (2021-2030)
• Table 22 Cerebrospinal Fluid Management Market in Germany (2021-2030)
• Table 23 Cerebrospinal Fluid Management Market in the United Kingdom (2021-2030)
• Table 24 Cerebrospinal Fluid Management Market in Italy (2021-2030)
• Table 25 Cerebrospinal Fluid Management Market in Spain (2021-2030)
• Table 26 Cerebrospinal Fluid Management Market in Russia (2021-2030)
• Table 27 Cerebrospinal Fluid Management Market in Rest of Europe (2021-2030)
• Table 28 Cerebrospinal Fluid Management Market in APAC (2021-2030)
• Table 29 Cerebrospinal Fluid Management Market in APAC by Product Type (2021-2030)
• Table 30 Cerebrospinal Fluid Management Market in APAC by Age Group (2021-2030)
• Table 31 Cerebrospinal Fluid Management Market in APAC by End User (2021-2030)
• Table 32 Cerebrospinal Fluid Management Market in APAC by Country (2021-2030)
• Table 33 Cerebrospinal Fluid Management Market in China (2021-2030)
• Table 34 Cerebrospinal Fluid Management Market in Japan (2021-2030)
• Table 35 Cerebrospinal Fluid Management Market in India (2021-2030)
• Table 36 Cerebrospinal Fluid Management Market in Australia (2021-2030)
• Table 37 Cerebrospinal Fluid Management Market in South Korea (2021-2030)
• Table 38 Cerebrospinal Fluid Management Market in Rest of APAC (2021-2030)
• Table 39 Cerebrospinal Fluid Management Market in Rest of World (2021-2030)
• Table 40 Cerebrospinal Fluid Management Market in RoW by Product Type (2021-2030)
• Table 41 Cerebrospinal Fluid Management Market in RoW by Age Group (2021-2030)
• Table 42 Cerebrospinal Fluid Management Market in RoW by End User (2021-2030)
• Table 43 Cerebrospinal Fluid Management Market in RoW by Region (2021-2030)
• Table 44 Cerebrospinal Fluid Management Market in Middle East (2021-2030)
• Table 45 Cerebrospinal Fluid Management Market in Africa (2021-2030)
• Table 46 Cerebrospinal Fluid Management Market in South America (2021-2030)

List of Figures

Figures 1 Competitive Analysis

Figures 2 COVID-19 Impact Analysis on Cerebrospinal Fluid Management Market

Figures 3 Cerebrospinal Fluid Management Market in Global (2021-2030)

Figures 4 Cerebrospinal Fluid Management Market in Global by Product Type (2021-2030)

Figures 5 Cerebrospinal Fluid Management Market in Global by Age Group (2021-2030)

Figures 6 Cerebrospinal Fluid Management Market in Global by End User (2021-2030)

Figures 7 Cerebrospinal Fluid Management Market in Global by Geography (2021-2030)

Figures 8 Cerebrospinal Fluid Management Market in North America (2021-2030)

Figures 9 Cerebrospinal Fluid Management Market in North America by Product Type (2021-2030)

Figures 10 Cerebrospinal Fluid Management Market in North America by Age Group (2021-2030)

Figures 11 Cerebrospinal Fluid Management Market in North America by End User (2021-2030)

Figures 12 Cerebrospinal Fluid Management Market in North America by Country (2021-2030)

Figures 13 Cerebrospinal Fluid Management Market in the US (2021-2030)

Figures 14 Cerebrospinal Fluid Management Market in Canada (2021-2030)

Figures 15 Cerebrospinal Fluid Management Market in Mexico (2021-2030)

Figures 16 Cerebrospinal Fluid Management Market in Europe (2021-2030)

Figures 17 Cerebrospinal Fluid Management Market in Europe by Product Type (2021-2030)

Figures 18 Cerebrospinal Fluid Management Market in Europe by Age Group (2021-2030)

Figures 19 Cerebrospinal Fluid Management Market in Europe by End User (2021-2030)

Figures 20 Cerebrospinal Fluid Management Market in Europe by Country (2021-2030)

Figures 21 Cerebrospinal Fluid Management Market in France (2021-2030)

Figures 22 Cerebrospinal Fluid Management Market in Germany (2021-2030)

Figures 23 Cerebrospinal Fluid Management Market in the United Kingdom (2021-2030)

Figures 24 Cerebrospinal Fluid Management Market in Italy (2021-2030)

Figures 25 Cerebrospinal Fluid Management Market in Spain (2021-2030)

Figures 26 Cerebrospinal Fluid Management Market in Russia (2021-2030)

Figures 27 Cerebrospinal Fluid Management Market in Rest of Europe (2021-2030)

Figures 28 Cerebrospinal Fluid Management Market in APAC (2021-2030)

Figures 29 Cerebrospinal Fluid Management Market in APAC by Product Type (2021-2030)

Figures 30 Cerebrospinal Fluid Management Market in APAC by Age Group (2021-2030)

Figures 31 Cerebrospinal Fluid Management Market in APAC by End User (2021-2030)

Figures 32 Cerebrospinal Fluid Management Market in APAC by Country (2021-2030)

Figures 33 Cerebrospinal Fluid Management Market in China (2021-2030)

Figures 34 Cerebrospinal Fluid Management Market in Japan (2021-2030)

Figures 35 Cerebrospinal Fluid Management Market in India (2021-2030)

Figures 36 Cerebrospinal Fluid Management Market in Australia (2021-2030)

Figures 37 Cerebrospinal Fluid Management Market in South Korea (2021-2030)

Figures 38 Cerebrospinal Fluid Management Market in Rest of APAC (2021-2030)

Figures 39 Cerebrospinal Fluid Management Market in Rest of World (2021-2030)

Figures 40 Cerebrospinal Fluid Management Market in RoW by Product Type (2021-2030)

Figures 41 Cerebrospinal Fluid Management Market in RoW by Age Group (2021-2030)

Figures 42 Cerebrospinal Fluid Management Market in RoW by End User (2021-2030)

Figures 43 Cerebrospinal Fluid Management Market in RoW by Region (2021-2030)

Figures 44 Cerebrospinal Fluid Management Market in Middle East (2021-2030)

Figures 45 Cerebrospinal Fluid Management Market in Africa (2021-2030)

Figures 46 Cerebrospinal Fluid Management Market in South America (2021-2030)

Figures 47 Market Drivers

Figures 48 Market Barriers

Figures 49 Marker Opportunities

Figures 50 PORTER'S Five Force Analysis